Recall of cobas e 411 analyser. An in vitro diagnostic medical device (IVD)

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by Roche Diagnostics Australia Pty Limited.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    RC-2017-RN-00847-1
  • Event Risk Class
    Class II
  • Event Initiated Date
    2017-07-07
  • Event Country
  • Event Source
    DHTGA
  • Event Source URL
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Extra notes in the data
  • Reason
    Roche diagnostics have identified that in very rare cases, a software malfunction in the “sample & control” data file may occur, which could lead to a potential sample mismatch (incorrect test order and incorrect result reporting). the impact of any data mismatch cannot be predicted. the system may still be used routinely as long as the workaround and corrective actions are taken into account. this software malfunction can only occur:- when the “sample data clear” function is not performed routinely as indicated in the operator’s manual; and- when the “sample & control” datafile of the cobas e 411 analyser is filled with = 2,000 records.All tests run on the cobas e 411 analyser are potentially affected if these criteria are met. the extent of the bias cannot be predicted and the detectability of this issue is not certain. a relevant medical risk cannot be entirely excluded.A small number of complaints have been received, however none from australian customers, to date.
  • Action
    Roche Diagnostics is requesting that customers adhere to the following: 1. Until the software update has been installed, it is MANDATORY to perform a “Sample Data Clear” daily: “Sample Data Clear” is step no. 2 in the Work Flow Guide in the System Overview window. Please note: A Sample Data Clear deletes all sample records and moves QC data to the QC view. It is recommended to perform the backup procedure on a regular basis, depending on the data volume at the laboratory site. If the system is connected to a host, ensure that all data has been uploaded before performing a sample data clear. 2. Follow the instructions given in the customer letter supplied and then display it in a prominent place in the laboratory until the mandatory software upgrade has been installed.

Device

  • Model / Serial
    cobas e 411 analyser. An in vitro diagnostic medical device (IVD)cobas e 411 analyser (disk system)Material Number: 04775279001cobas e 411 analyser (rack system)Material Number: 04775201001All Software versionsARTG Number: 173887
  • Manufacturer

Manufacturer